Marksans Pharma consolidated net profit rises 26.80% in the June 2021 quarter

Sales rise 5.38% to Rs 348.96 crore

Net profit of Marksans Pharma rose 26.80% to Rs 62.60 crore in the quarter ended June 2021 as against Rs 49.37 crore during the previous quarter ended June 2020. Sales rose 5.38% to Rs 348.96 crore in the quarter ended June 2021 as against Rs 331.15 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales348.96331.15 5 OPM %22.1621.14 -PBDT82.2668.65 20 PBT74.7861.40 22 NP62.6049.37 27

Powered by Capital Market - Live News